Erratum: Hck/Fgr Kinase Deficiency Reduces Plaque Growth and Stability by Blunting Monocyte Recruitment and Intraplaque Motility (Circulation (2015) 132 (490–501) DOI: 10.1161/CIRCULATIONAHA.114.012316);Hck/Fgr Kinase Deficiency Reduces Plaque Growth and Stability by Blunting Monocyte Recruitment and Intraplaque Motility

Circulation

Volumn 132, Issue 6, 2015, Pages 490-501

  Medina, Indira ^a,b   Cougoule, Céline ^c,d   Drechsler, Maik ^e   Bermudez, Beatriz ^f   Koenen, Rory R ^e   Sluimer, Judith ^a   Wolfs, Ine ^a   Döring, Yvonne ^e   Herias, Veronica ^a   Gijbels, Marjon ^a   Bot, Ilze ^b   De Jager, Saskia C A ^b   Weber, Christian ^e   Cleutjens, Jack ^a   Van Berkel, Theo J C ^b   Sikkink, Kees Jan ^g   Mócsai, Atilla ^h   Maridonneau Parini, Isabelle ^c,d   Soehnlein, Oliver ^e,i,j   Biessen, Erik A L ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^d UNIVERSITÉ DE TOULOUSE   (France)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f INSTITUTO DE LA GRASA   (Spain)

^g Orbis Medical Centre Sittard   (Netherlands)

^h SEMMELWEIS UNIVERSITY   (Hungary)

ⁱ ACADEMIC MEDICAL CENTER   (Netherlands)

^j DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

more..

Author keywords

atherosclerosis; cell migration assays; immunology; leukocytes; mobility; phosphotransferases; plaque, atherosclerotic

Indexed keywords

COLLAGEN TYPE 1; FIBRILLAR COLLAGEN; GELATINASE A; GELATINASE B; HEMATOPOIETIC CELL KINASE; MESSENGER RNA; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE FGR; UNCLASSIFIED DRUG; HCK PROTEIN, MOUSE; LOW DENSITY LIPOPROTEIN RECEPTOR; ONCOPROTEIN; PROTO-ONCOGENE PROTEINS C-FGR; SCLEROPROTEIN;

ADHERENT CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; BONE MARROW CELL; BONE MARROW DERIVED MACROPHAGE; BONE MARROW TRANSPLANTATION; CAROTID ARTERY; CELL ADHESION; CELL PROLIFERATION; CHIMERA; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME DEFICIENCY; EROSION; EXTRACELLULAR MATRIX; FILOPODIUM; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE DELETION; GRANULOCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; LAMELLIPODIUM; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION; MONOCYTE; MONOCYTOSIS; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEUM MACROPHAGE; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY; ANIMAL; APOPTOSIS; C57BL MOUSE; CELL CULTURE; CELL SURFACE; DEFICIENCY; ENDOTHELIUM CELL; ENZYMOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; KNOCKOUT MOUSE; LEUKOCYTE ROLLING; METABOLISM; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PHAGOCYTOSIS; PHYSIOLOGY; RADIATION CHIMERA; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; ULTRASTRUCTURE;

ANIMALS; APOPTOSIS; CELL ADHESION; CELL SURFACE EXTENSIONS; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LEUKOCYTE ROLLING; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; PHAGOCYTOSIS; PLAQUE, ATHEROSCLEROTIC; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-HCK; RADIATION CHIMERA; RECEPTORS, LDL; SRC-FAMILY KINASES; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

EID: 84939454889     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0000000000000965     Document Type: Erratum

References (33)

1. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 2011;11:723-737. doi: 10.1038/nri3073.
2. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7:678-689. doi: 10.1038/nri2156.
3. Rikitake Y, Takai Y. Directional cell migration regulation by small G proteins, nectin-like molecule-5, and afadin. Int Rev Cell Mol Biol. 2011;287:97-143. doi: 10.1016/B978-0-12-386043-9.00003-7.
4. Muller WA. Mechanisms of leukocyte transendothelial migration. Annu Rev Pathol. 2011;6:323-344. doi: 10.1146/annurev-pathol-011110-130224.
5. Yago T, Shao B, Miner JJ, Yao L, Klopocki AG, Maeda K, Coggeshall KM, McEver RP. E-selectin engages PSGL-1 and CD44 through a common signaling pathway to induce integrin alphaLbeta2-mediated slow leukocyte rolling. Blood. 2010;116:485-494. doi: 10.1182/blood-2009-12-259556.
6. Zarbock A, Abram CL, Hundt M, Altman A, Lowell CA, Ley K. PSGL-1 engagement by E-selectin signals through Src kinase Fgr and ITAM adapters DAP12 and FcR gamma to induce slow leukocyte rolling. J Exp Med. 2008;205:2339-2347. doi: 10.1084/jem.20072660.
7. Baruzzi A, Caveggion E, Berton G. Regulation of phagocyte migration and recruitment by Src-family kinases. Cell Mol Life Sci. 2008;65:2175-2190. doi: 10.1007/s00018-008-8005-6.
8. Harb D, Bujold K, Febbraio M, Sirois MG, Ong H, Marleau S. The role of the scavenger receptor CD36 in regulating mononuclear phagocyte trafficking to atherosclerotic lesions and vascular inflammation. Cardiovasc Res. 2009;83:42-51. doi: 10.1093/cvr/cvp081.
9. Hilgendorf I, Eisele S, Remer I, Schmitz J, Zeschky K, Colberg C, Stachon P, Wolf D, Willecke F, Buchner M, Zirlik K, Ortiz-Rodriguez A, Lozhkin A, Hoppe N, von zur Muhlen C, zur Hausen A, Bode C, Zirlik A. The oral spleen tyrosine kinase inhibitor fostamatinib attenuates inflammation and atherogenesis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2011;31:1991-1999. doi: 10.1161/ATVBAHA.111.230847.
10. Katsume A, Okigaki M, Matsui A, Che J, Adachi Y, Kishita E, Yamaguchi S, Ikeda K, Ueyama T, Matoba S, Yamada H, Matsubara H. Early inflammatory reactions in atherosclerosis are induced by proline-rich tyrosine kinase/reactive oxygen species-mediated release of tumor necrosis factor-alpha and subsequent activation of the p21Cip1/Ets-1/p300 system. Arterioscler Thromb Vasc Biol. 2011;31:1084-1092. doi: 10.1161/ATVBAHA.110.221804.
11. Shah Z, Kampfrath T, Deiuliis JA, Zhong J, Pineda C, Ying Z, Xu X, Lu B, Moffatt-Bruce S, Durairaj R, Sun Q, Mihai G, Maiseyeu A, Rajagopalan S. Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis. Circulation. 2011;124:2338-2349. doi: 10.1161/CIRCULATIONAHA.111.041418.
12. Berton G, Mócsai A, Lowell CA. Src and Syk kinases: key regulators of phagocytic cell activation. Trends Immunol. 2005;26:208-214. doi: 10.1016/j.it.2005.02.002.
13. Cougoule C, Le Cabec V, Poincloux R, Al Saati T, Mège JL, Tabouret G, Lowell CA, Laviolette-Malirat N, Maridonneau-Parini I. Threedimensional migration of macrophages requires Hck for podosome organization and extracellular matrix proteolysis. Blood. 2010;115:1444-1452. doi: 10.1182/blood-2009-04-218735.
14. Bhattacharjee A, Pal S, Feldman GM, Cathcart MK. Hck is a key regulator of gene expression in alternatively activated human monocytes. J Biol Chem. 2011;286:36709-36723. doi: 10.1074/jbc.M111.291492.
15. Lowell CA. Src-family and Syk kinases in activating and inhibitory pathways in innate immune cells: signaling cross talk. Cold Spring Harb Perspect Biol. 2011;3:. doi: 10.1101/cshperspect.a002352.
16. Cougoule C, Carréno S, Castandet J, Labrousse A, Astarie-Dequeker C, Poincloux R, Le Cabec V, Maridonneau-Parini I. Activation of the lysosome-associated p61Hck isoform triggers the biogenesis of podosomes. Traffic. 2005;6:682-694. doi: 10.1111/j.1600-0854.2005.00307.x.
17. Sambrook J, Russell DW. Extraction, purification and analysis of mRNA from eukaryotic cells. In: Argentine J, Irwin N, Janssen KA, Curtis S, Zierler M, eds. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2001:7.4-7.9
18. Fuentes-Duculan J, Suárez-Farinãs M, Zaba LC, Nograles KE, Pierson KC, Mitsui H, Pensabene CA, Kzhyshkowska J, Krueger JG, Lowes MA. A subpopulation of CD163-positive macrophages is classically activated in psoriasis. J Invest Dermatol. 2010;130:2412-2422. doi: 10.1038/jid.2010.165.
19. Hatakeyama S, Iwabuchi K, Ogasawara K, Good RA, Onoé K. The murine c-fgr gene product associated with Ly6C and p70 integral membrane protein is expressed in cells of a monocyte/macrophage lineage. Proc Natl Acad Sci USA. 1994;91:3458-3462.
20. Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, Llodra J, Garin A, Liu J, Mack M, van Rooijen N, Lira SA, Habenicht AJ, Randolph GJ. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest. 2007;117:185-194. doi: 10.1172/JCI28549.
21. Van Goethem E, Poincloux R, Gauffre F, Maridonneau-Parini I, Le Cabec V. Matrix architecture dictates three-dimensional migration modes of human macrophages: differential involvement of proteases and podosome-like structures. J Immunol. 2010;184:1049-1061. doi: 10.4049/jimmunol.0902223.
22. Van Goethem E, Guiet R, Balor S, Charrière GM, Poincloux R, Labrousse A, Maridonneau-Parini I, Le Cabec V. Macrophage podosomes go 3D. Eur J Cell Biol. 2011;90:224-236. doi: 10.1016/j.ejcb.2010.07.011.
23. Wiesner C, Le-Cabec V, El Azzouzi K, Maridonneau-Parini I, Linder S. Podosomes in space: macrophage migration and matrix degradation in 2D and 3D settings. Cell Adh Migr. 2014;8:179-191.
24. Murphy DA, Courtneidge SA. The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function. Nat Rev Mol Cell Biol. 2011;12:413-426. doi: 10.1038/nrm3141.
25. Swirski FK, Libby P, Aikawa E, Alcaide P, Luscinskas FW, Weissleder R, Pittet MJ. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest. 2007;117:195-205. doi: 10.1172/JCI29950.
26. Robbins CS, Swirski FK. The multiple roles of monocyte subsets in steady state and inflammation. Cell Mol Life Sci. 2010;67:2685-2693. doi: 10.1007/s00018-010-0375-x.
27. Combadière C, Potteaux S, Gao JL, Esposito B, Casanova S, Lee EJ, Debré P, Tedgui A, Murphy PM, Mallat Z. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation. 2003;107:1009-1016.
28. Cheng C, Tempel D, van Haperen R, de Boer HC, Segers D, Huisman M, van Zonneveld AJ, Leenen PJ, van der Steen A, Serruys PW, de Crom R, Krams R. Shear stress-induced changes in atherosclerotic plaque composition are modulated by chemokines. J Clin Invest. 2007;117:616-626. doi: 10.1172/JCI28180.
29. Martínez-Hervás S, Vinué A, Núñez L, Andrés-Blasco I, Piqueras L, Real JT, Ascaso JF, Burks DJ, Sanz MJ, González-Navarro H. Insulin resistance aggravates atherosclerosis by reducing vascular smooth muscle cell survival and increasing CX3CL1/CX3CR1 axis. Cardiovasc Res. 2014;103:324-336.
30. Ridley AJ. Life at the leading edge. Cell. 2011;145:1012-1022. doi: 10.1016/j.cell.2011.06.010.
31. Sun X, Phan TN, Jung SH, Kim SY, Cho JU, Lee H, Woo SH, Park TK, Yang BS. LCB 03-0110, a novel pan-discoidin domain receptor/c-Src family tyrosine kinase inhibitor, suppresses scar formation by inhibiting fibroblast and macrophage activation. J Pharmacol Exp Ther. 2012;340:510-519. doi: 10.1124/jpet.111.187328.
32. Skhirtladze C, Distler O, Dees C, Akhmetshina A, Busch N, Venalis P, Zwerina J, Spriewald B, Pileckyte M, Schett G, Distler JH. Src kinases in systemic sclerosis: central roles in fibroblast activation and in skin fibrosis. Arthritis Rheum. 2008;58:1475-1484. doi: 10.1002/art.23436.
33. Beyer C, Distler O, Distler JH. Innovative antifibrotic therapies in systemic sclerosis. Curr Opin Rheumatol. 2012;24:274-280. doi: 10.1097/BOR.0b013e3283524b9a.